We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALOPM market cap is 23.65M. The company's latest EPS is EUR -0.4448 and P/E is -2.92.
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
EUR (€) | EUR (€) | |
Total Revenue | 8.27M | 1.08M |
Operating Income | -1.61M | -9.94M |
Net Income | -231k | -8.09M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
EUR (€) | EUR (€) | |
Total Assets | 18.37M | 16.63M |
Total Liabilities | 8.53M | 14.88M |
Total Equity | 9.84M | 1.75M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
EUR (€) | EUR (€) | |
Operating | N/A | N/A |
Investing | N/A | N/A |
Financing | N/A | N/A |
Market Cap | 23.65M |
Price to Earnings Ratio | -2.92 |
Price to Sales Ratio | 21.92 |
Price to Cash Ratio | 73.45 |
Price to Book Ratio | 13.51 |
Dividend Yield | - |
Shares Outstanding | 18.19M |
Average Volume (1 week) | 11.11k |
Average Volume (1 Month) | 8.15k |
52 Week Change | 22.64% |
52 Week High | 2.39 |
52 Week Low | 1.04 |
Spread (Intraday) | 0.03 (2.26%) |
Company Name | Oncodesign Precision Medicine SA |
Address |
18 rue jean mazen dijon, cote-d'or 21000 |
Website | https://www.oncodesign.com |
Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions